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critically ill patientDear Editor,
Organizing pneumonia is characterized by fibroblastic pro-
liferation in the distal airways with an inflammatory
response in different pulmonary situations.1 Cytomegalo-
virus (CMV)-associated organizing pneumonia was very
rarely reported and only limited to post-transplant re-
cipients.2 Ventilator-associated CMV pneumonia of immu-
nocompetent patients has been described.3,4 However,
CMV organizing pneumonia has not been mentioned in these
patients.
A 64-year-old diabetic man had acute respiratory failure
and was admitted to an intensive care unit on September 5,
2012. His blood urea nitrogen was 215 mg/dL; creatinine
15.47 mg/dL; K 6.55 mEq/L; white blood cell count 15,900/
mL; hemoglobin 11.3 g/dL; and platelet count 98,000/mL.
The patient received continuous veno-veno hemofiltration
followed by maintenance hemodialysis. The institutional
review board of the Chi Mei Medical Center, Taiwan
approved the study of the patient (no. 10111-014) with
informed family consent.
On September 8, a chest radiograph showed predomi-
nately right lung infiltrates (Fig. 1A). The sputum culture
yielded carbapenem-resistant Acinetobacter baumannii
(CRAB). The patient received 1 week of cefpirome plus
sulbactam and a subsequent 2 weeks of ceftazidime plus
colistin. However, right pneumonia became more extensive
(Fig. 1A). The antibiotic therapy was replaced by mer-
openem plus colistin. On October 17, parenteral ganciclovir
was added as delayed resolution of pneumonia (Fig. 1A) and
the patient tested positive in a CMV-polymerase chain re-
action (PCR) of blood and endobronchial sputum. Computed
tomography of the chest showed multiple poorly enhanced
consolidative patches with air bronchograms particularly on
the right lung (Fig. 1B). Bronchoscopic study showed some
ulceration and granulomatous-like tissue over the bronchial
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ening pneumonia after ganciclovir therapy (Fig. 1C).
A right lung biopsy by means of video-assisted thoraco-
scopic surgery was performed on October 25. The resected
lung tissue culture did not yield any bacterial organism. The
lung tissue pathology reported organizing pneumonia as
alveolar spaces were filled with fibrin and foamy histio-
cytes. Because CMV pneumonia was not mentioned, gan-
ciclovir therapy was de-escalated to valganciclovir.
However, the blood CMV-PCR obtained on November 8
remained positive. The pneumonia persisted without sig-
nificant resolution (Fig. 1C). At this time point, we
requested additional CMV immunohistochemical staining on
the initial lung biopsy. CMV pneumonia was then confirmed
by the presence of enlarged cells with eosinophilic inclusion
bodies, which was positive for CMV immunohistochemical
stain (Fig. 1D).
On November 12, the patient died in septic shock due to
double lumen-associated enterococcal bacteremia. Final
needle necropsy of the right lung revealed CMV pneumonia,
suggesting poor therapeutic response to ganciclovir (100 mg
every other day) for 10 days and subsequent 2-week val-
ganciclovir therapy (450 mg p.o. every other day). The re-
sults of sputum and resected lung tissue cultures for
Mycobacterium tuberculosis were no growth.
The poor antiviral effects in our case may be due to early
de-escalation of parenteral ganciclovir to oral valganciclo-
vir when CMV was missed in the initial biopsies. A longer
duration of parenteral ganciclovir induction therapy for
2e3 weeks may be required to treat severe CMV pneumonia
with slow resolution or persistent viremia on treatment.5
In conclusion, earlier diagnosis and prompt antiviral
therapy for ventilator-associated CMV organizing pneu-
monia should be emphasized. CMV immunohistochemical
staining improves the diagnostic yield of CMV tests on the
biopsies.d cytomegalovirus organizing pneumonia in an immunocompetent
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Figure 1. (A) Ventilator-associated pneumonia with delayed resolution for more than 1 month. (B) The computed tomography of
the chest showing multiple poorly enhanced consolidative patches with air bronchograms particularly on the right lung and pleural
effusion on the left side. (C) The pneumonia showing untoward response to ganciclovir therapy (left), becoming organizing
pneumonia (middle), and persistence without significant change (right). (D) Open biopsy from the right lung (C, middle) showing
organizing pneumonia and an enlarged cell with eosinophilic inclusion body (left, arrow), which is positive for Cytomegalovirus
(CMV) immunohistochemical staining (right, arrow).
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